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Abstract A complementary DNA encoding a novel human 
protein phosphatase 1 (PP1) glycogen-targetting subunit of 
molecular mass 33 kDa has been sequenced. PPP1R6 is 31% 
identical to the glycogen-targetting subunit (GL) of PP1 from rat 
liver, 28% identical to the N-terminal region of the glycogen-
targetting subunit (GM) from human skeletal muscle and 27% 
identical to glycogen-targetting subunit PPP1R5. Unlike human 
PPP1R5 and its murine homologue PTG, whose mRNAs are 
most abundant in skeletal muscle, heart and liver, PPP1R6 is 
present at similar levels in a wide variety of tissues. The PPP1R6 
is associated with glycogen in muscle but is not subject to the 
same modes of covalent and allosteric regulation as G M and GL. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Protein phosphatase 1 (PP1) is known to form distinct com-
plexes with more than 20 different proteins that allow it to 
carry out a wide variety of functions by targetting PP1 to 
various subcellular locations. For example, glycogen binding 
subunits target PP1 to glycogen particles, the myosin binding 
subunits target PP1 to the muscle contractile apparatus , while 
PP1 is associated with several different binding subunits in the 
nucleus. Interaction of PP1 with these targetting subunits fre-
quently changes the substrate specificity of PP1 and may also 
allow PP1 complexes to be regulated by extracellular signals 
[1,2]. A short motif -(R/K)(V/I)xF- was recently shown to be 
sufficient for binding of these otherwise dissimilar subunits to 
PP1 , and the presence of this motif in most of the known PP1 
binding subunits explains why the interaction of these target-
ting subunits with PP1 is mutually exclusive [2,3]. 
PP1 plays a key role in the regulation of glycogen metabo-
lism, through the dephosphorylation of glycogen synthase, 
phosphorylase and phosphorylase kinase. Three distinct gly-
cogen-targetting subunits of PP1 have been identified. The 
skeletal muscle glycogen-targetting subunit G M [4], which is 
also present in diaphragm and heart muscle, has been cloned 
from rabbit (termed R Q I ) [5] and human tissues (termed 
PPP1R3 in the human genome nomenclature) [6]. Cloning 
of the 33 k D a liver specific PP1 glycogen-targetting subunit 
G L (PPP1R4) from rat [7], showed that al though it was only 
2 3 % identical to the N-terminal third of the 126 k D a G M 
subunit, conserved regions presumed to be involved in binding 
PP1 and glycogen could be identified. Determination of the 
crystal structure of P P l y i n complex with a 13 residue peptide 
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from one of these regions, delineated the -(R/K)(V/I)xF- PP1 
binding motif in G M [3]. More recently, we identified a further 
36 k D a glycogen-targetting subunit, termed human PPP1R5, 
which was most highly expressed in skeletal muscle and liver, 
but the m R N A was also present in a wide variety of other 
tissues. Comparison of the amino acid sequences of G M , G L 
and PPP1R5 with the S. cerevisiae glycogen binding subunit 
G a e l [8] and Rhizopus oryzae glucoamylase [9] identified a 
putative glycogen/starch binding domain [10]. A murine gly-
cogen-targetting subunit termed P T G [11] and chicken glyco-
gen-targetting subunit U5 [12] appear to be homologues of 
human PPP1R5 (see Section 4). We describe here the identi-
fication of a fourth glycogen-targetting subunit which is ex-
pressed in many human tissues. 
2. Materials and methods 
2.1. Identification and characterisation of the cDNA encoding human 
protein phosphatase 1 binding subunit R6, PPP1R6 
The National Centre for Biotechnology Information (NCBI) ex-
pressed sequence tag database was searched for sequences related to 
the putative glycogen binding region of the rat liver glycogen-target-
ting subunit (GL) and PPP1R5, using the TBLASTN algorithm. Two 
overlapping cDNA clones in the plasmids Lafmid BA and pT7T3D 
were kindly provided by the IMAGE consortium, St. Louis. They 
were sequenced in their respective plasmids in both directions on an 
Applied Biosystems 373A automated DNA sequencer using Taq dye 
terminator cycle sequencing. One of the clones, 31199 in Lafmid BA, 
contained the full open reading frame of a protein with sequence 
similarity to rat GL, hereafter termed PPP1R6. 
2.2. Expression of PPP1R6 mRNA in human tissues 
A Northern blot (Clontech, Palo Alto, CA) containing poly (A)+ 
RNA from different human tissues was hybridised with an 850 bp 
BamHl fragment encoding amino acids 15-394 of PPP1R6 labelled 
with [a-32P]dATP, according to the manufacturer's instructions. The 
blot was washed at 60°C in 15 mM NaCl, 1.5 mM sodium citrate, 
0.1% SDS. Following autoradiography, the blot was stripped by 
washing the membrane in 0.5% SDS at 100°C for 5 min. The blot 
was subsequently reprobed with either the full length coding region of 
PPP1R5 [10], the HIG 11 fragment of skeletal muscle GM, encoding 
amino acids 2-687 [6], or a control P-actin probe (Clontech). 
2.3. Heterologous expression of GST-PP1R6 in E. coli 
IMAGE clone 31199 was used as a template in a polymerase chain 
reaction (PCR) with the oligonucleotide primers 5'-GCGCGAATT-
CATATGTCCAGAGGCCCGAGCTCC-3' and 5'-GCGCAAGCT-
TCAGATGAAGTGGATCCAGCTC-3'. This produced a full length 
PPP1R6 coding region with an Ndel site 5' of the initiating ATG and 
a Hindlll site 3' of the termination codon (sites underlined). The PCR 
product was subcloned into the TOPO 2.1 PCR cloning vector and 
transfected into TOP10 cells (Invitrogen, NV Leek, The Netherlands) 
for verification by sequencing. The PPP1R6 coding region was sub-
sequently excised by restriction digestion with Ndel and Hindlll and 
ligated into the pGEX-AH vector digested with the same restriction 
enzymes. The resultant construct encoded glutathione S-transferase 
(GST) fused to full length PPP1R6. Soluble GST-PPP1R6 was ob-
tained by growing pGEX-AH/PPPlR6 transformed E. coli in LB 
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medium containing 100 ug/ml ampicillin and inducing expression of 
GST-PPP1R6 in log phase at an Am nm of 0.5 with 0.2 mM isoprop-
yl-thio-P-D-galactopyranoside. The cells were harvested after 16 h in-
cubation at 28°C and soluble GST-PPP1R6 was purified as described 
m-
2.4. Interaction of digoxygenin-PPl with the PPP1R6 
The PPlg isoform (40 u.g) was labelled with the ester of digoxygen-
in-3-O-methylcarbonyl-e-aminocaproic-acid-JV-hydroxysuccinimide 
(Boehringer Mannheim, Germany) and separated from excess reagent 
according to the manufacturer's instructions. 
Protein samples were separated by SDS-PAGE and transferred to a 
nitrocellulose membrane. Non-specific binding to the membrane was 
blocked by incubation for 16 h at room temperature in 5% (w/v) 
Marvel dried milk powder in 25 mM Tris/HCl (pH 7.5), 250 mM 
NaCl. The membrane was then washed several times before incuba-
tion for 2 h with digoxygenin-PPl diluted to 2.5 ug/ml in 25 mM Tris/ 
HC1 (pH 7.5), 250 mM NaCl, 1 mg/ml bovine serum albumin (BSA). 
The nitrocellulose membrane was washed extensively in several 
changes of 25 mM Tris/HCl (pH 7.5), 250 mM NaCl for 2 h and 
then probed for 1 h with anti-digoxygenin conjugated with horse 
radish peroxidase at a concentration of 150 mU peroxidase/ml (Boeh-
ringer) in 25 mM Tris/HCl (pH 7.5), 250 mM NaCl containing 5% 
(w/v) Marvel. The membrane was subsequently washed for 3 h in 25 
mM Tris/HCl (pH 7.5), 250 mM NaCl and the proteins binding to 
digoxygenin labelled PP1 were visualised with the enhanced chemilu-
minescence system (Amersham International, Bucks, UK). 
2.5. Production of PPP1R6 antibodies 
The peptide RPIIQRRSRSLPTSPE corresponding to residues 48-
63 of the rat sequence obtained from the NCBI expressed sequence 
tag database (corresponding to amino acids 65-80 in human PPP1R6) 
were conjugated to BSA and keyhole limpet haemocyanin and in-
jected into a sheep at the Scottish Antibody Production Unit (Car-
luke, Ayrshire, UK). The antibodies were affinity purified by chroma-
tography of the anti-serum on peptide-CH-Sepharose columns. These 
anti-PPPlR6 antibodies recognised 1 ng of human GST-PPP1R6 but 
did not cross-react with 500 ng of GST-PPP1R5, G S T - G M (1-243) or 
G S T - G L (data not shown). 
2.6. Isolation of the glycogenlsarcovesicle fraction from rabbit skeletal 
muscle 
The skeletal muscle from one female New Zealand White rabbit 
was homogenised in 2 mM EGTA, 2 mM EDTA, pH 7.0, 0.1% 2-
mercaptoethanol, 0.5 mM PhMeSC^F, 1 mM benzamidine, 4 ug/ml 
leupeptin and a fraction containing glycogen particles and vesicular 
fragments of the sarcoplasmic reticulum was isolated as described in 
[13]. The pH 6.1 pellet was then resuspended in 30 ml of 0.1 M 
sodium glycerol-2-phosphate, 0.1 mM EGTA, 0.5 mM PhMeS02F, 
1 mM benzamidine, 4 ug/ml leupeptin and centrifuged at lOOOOOXg 
for 90 min. The supernatant was discarded and the glycogen/sarcove-
sicle pellet was resuspended in 100 ml of 50 mM Tris-HCl pH 7.5, 0.1 
mM EGTA, 5% glycerol, 0.5 mM PhMeS02F, 1 mM benzamidine, 
4 ug/ml leupeptin, 0.1% 2-mercaptoethanol and recentrifuged. The 
resulting pellet was again resuspended in 30 ml of the same buffer. 
3. Results 
3.1. Human protein phosphatase 1 binding subunit R6 is related 
to the glycogen-targetting subunits of PP1 
A search of the NCBI expressed sequence tag database with 
the putative glycogen binding region of rat G L and human 
PPP1R5 proteins identified two partially sequenced c D N A s 
coding for proteins displaying significant similarity to these 
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Fig. 1. Nucleotide and predicted amino-acid sequence of human protein phosphatase 1 binding subunit R6, PPP1R6. 
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Fig. 2. Comparison of the amino-acid sequence of human PPP1R6 with rat GL, the N-terminal 1-284 amino acids of human GM and human 
PPP1R5. Identities are underlined. Residues corresponding to the -(R/K)(V/I)xF- PPl binding motif are indicated by stars and the putative gly-
cogen binding region by double underlining. 
PPl binding subunits. One of the cDNA clones, which was 
derived from a human infant brain library, contained a com-
plete open reading frame encoding a putative protein of 299 
amino acids with a predicted molecular mass of 32.5 kDa 
(Fig. 1). The 5' untranslated region sequence preceding the 
putative initiating methionine conforms to the consensus se-
quence for eukaryotic translation initiation in 4 out of 6 nu-
cleotides [14]. In addition, a search of the NCBI database with 
the N-terminal 100 amino acids of PPP1R6 identified a partial 
rat sequence encoding the N-terminal 70 amino acids of an 
approximately 70% identical protein, but which diverged from 
the human PPP1R6 sequence immediately upstream of the 
putative initiating methionine. Following the termination co-
don at nucleotide 898 there are also 6 additional in frame stop 
codons. 
Comparison of the deduced amino acid sequence of human 
PPP1R6 with other glycogen-targetting subunits of PPl (Fig. 
2) shows that this novel protein is 31% identical to rat GL, 
28% to the N-terminal region of human GM and 27% to 
human PPP1R5. 
Analysis of the tissue distribution of PPP1R6 mRNA by 
Northern blotting shows that the PPP1R6 cDNA hybridises 
with two RNA species of 5.4 and 3.8 kb (Fig. 3A). These 
transcripts are detected in all tissues examined, with skeletal 
muscle and heart showing the highest amounts. In contrast, 
the other glycogen-targetting subunits have a more restricted 
expression pattern. The PPP1R5 transcript is expressed most 
abundantly in skeletal muscle, liver and heart (Fig. 3B), the 
GM transcripts are only expressed in striated muscles (Fig. 3C 
and see [5]), while the GL transcript is expressed exclusively in 
liver [7]. 
3.2. PPP1R6 binds to PPl and is associated with glycogen 
particles but not sarcovesicles of rabbit skeletal muscle 
The full length PPP1R6 cDNA sequence was expressed in 
E. coli as a GST-PPP1R6 fusion protein and purified to near 
homogeneity by affinity chromatography on reduced gluta-
thione-agarose. The purified GST-PPP1R6 preparation con-
sisted of the full length 58 kDa fusion protein and several 
smaller degradation products ranging in apparent molecular 
mass from 25-35 kDa (Fig. 4A). Only the 58 kDa GST-
PPP1R6 protein bound to digoxygenin-PPly (Fig. 4B). In 
contrast, some degradation products of G S T - G M , G S T - G L 
and GST-R5 as well as the entire fusion proteins were de-
tected by digoxygenin-PPly, presumably because they still 
contained the PPl binding region. The interactions with PPl 
were specific, since none of the molecular mass markers or the 
subunits of PP2Ai bound to digoxygenin-PPly (Fig. 4B). 
The PPP1R6 protein was found to be associated with a 
glycogen/sarcovesicle fraction from rabbit skeletal muscle as 
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Fig. 3. Tissue distribution of the PPP1R6 mRNA. A human multiple tissue Northern blot (Clontech) containing approximately 2 ug of poly 
(A)+ RNA per lane, was hybridised with cDNA probes to either human PPP1R6, designated R6 (A), PPP1R5, designated R5 (B), GM (C) or 
a control probe, p-actin (D). Transcript sizes are indicated by arrows and calculated by their mobility relative to RNA standards. 
judged by immunoblotting (Section 2.5, Fig. 5). In order to 
determine whether the protein was associated with glycogen 
or the sarcovesicles, the glycogen/sarcovesicle fraction was 
either incubated with oc-amylase to degrade the glycogen, 
washed with Triton X-100 to solubilise the sarcovesicles, or 
subjected to both procedures. PPP1R6 immunoreactivity as-
sociated with the glycogen/sarcovesicle fractions was released 
by amylase treatment, but not by extraction with Triton X-
100 (Fig. 5), demonstrating that PPP1R6 is specifically asso-
ciated with glycogen particles. 
4. Discussion 
We have identified a fourth member of the family of glyco-
gen-targetting subunits of PP1, termed PPP1R6. Although 
human PPP1R6 is most closely related to rat GL, the low 
sequence identity to GL (31%) and the distinct tissue distribu-
tions of these proteins (Fig. 3 and [7]) exclude the possibility 
that PPP1R6 is the human homologue of rat GL. Moreover, 
an EST cDNA encoding part of the rat PPP1R6, which is 
approximately 70% identical to human PPP1R6 in the N-ter-
minal region, is present in the NCBI database. Since PPP1R6 
shows only low identity (<28%) to human PPP1R5 and hu-
man GM, PPP1R6 is clearly a novel PP1 glycogen-targetting 
subunit. A phylogenetic tree depicting the relationships be-
tween the known glycogen-targetting subunits in vertebrates 
is shown in Fig. 6. PPP1R5 [10] and murine PTG [11] appear 
to be species homologues since they show 85% identity and a 
similar tissue distribution. Although PTG was reported to be 
23 amino acids shorter at the N-terminus [11] than PPP1R5, 
translation of the 52 nucleotides in the '5 ' UTR' of PTG 
shows identity to PPP1R5 in 15 deduced amino acids preced-
Fig. 4. The GST-PPP1R6 protein shows specific binding to digoxy-
genin-PPl. One ug of GST-PPP1R6, GST-GM (1-243), GST-GL, 
GST-PPP1R5 and 1.5 ug of PP2Ai (comprising the catalytic subunit 
and regulatory A and B subunits) were separated by SDS-PAGE 
and either stained by Coomassie blue (A) or transferred to nitrocel-
lulose membrane and probed with digoxygenin-PPly (B). Binding of 
digoxygenin-PPl was visualised using with peroxidase conjugated 
anti-digoxygenin antibodies followed by enhanced chemilumines-
cence. The arrows show the position of full length GST-PPP1R6, 
GST and the molecular mass markers phosphorylase b (97 kDa), 
bovine serum albumin (66 kDa), ovalbumin (43 kDa) and carbonic 
anhydrase (29 kDa). 
Fig. 5. Association of PPP1R6 with glycogen particles in rabbit 
skeletal muscle. A skeletal muscle glycogen particle/sarcoplasmic re-
ticulum fraction was digested with 20 ug/ml human salivary a-amy-
lase for 45 min at 30°C, washed with 1% Triton X-100 or subjected 
to both procedures before centrifugation for 90 min at lOOOOOXg. 
The proteins in the resultant pellet and supernatant fractions were 
denatured in SDS, subjected to polyacrylamide gel electrophoresis, 
transferred to nitrocellulose membrane and probed with anti-
PPP1R6 antibodies. 
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Fig. 6. Phylogenetic tree depicting the relationship between the ver-
tebrate glycogen binding subunits. The sequences used are human 
PPP1R5 [10], murine PTG [11], chicken U5 [12], rat GL [7], human 
PPP1R6 (Fig. 1), the N-terminal regions of human GM (amino acids 
1-284) [6] and rabbit RGI (amino acids 1-286) [5]. The tree is de-
rived from distance matrices after progressive multiple alignment 
[19] using the SEQNET facility at Daresbury, UK. 
ing the residue that was presumed to be the initiating methio-
nine, with divergence only occurring at the extreme 5' end. 
This suggests that this region of the PTG mRNA is translated 
and that PPP1R5 and PTG have very similar, if not identical, 
N-terminal sequences. The protein U5 identified in smooth 
muscle may be the chicken homologue of PPP1R5, since it 
shows 47% identity to PPP1R5 and lower sequence identity to 
the other PP1 glycogen-targetting subunits ([12] and Fig. 6). 
Unlike GM, GL and PPP1R5, which are predominantly ex-
pressed in the major glycogen metabolising tissues, PPP1R6 
has a wide tissue distribution. The N-terminal half of PPP1R6 
possesses the sequence - R W F - which conforms to the mini-
mum PP1 binding motif -(R/K)(V/I)xF-. Comparison of the 
amino acid sequence of PPP1R6 with GM, GL and PPP1R5 
(Fig. 2) shows that the putative glycogen binding domain 
identified in these subunits [10] is present in the C-terminal 
half of PPP1R6. Immunoblotting studies established that 
PPP1R6 is specifically associated with glycogen particles and 
that, unlike GM [1], PPP1R6 is not associated with the sarco-
plasmic reticulum (Fig. 5). Therefore the function of PPP1R6 
is likely to be restricted to the regulation of glycogen-bound 
PP1. 
The P P 1 - G M complex dissociates in response to adrenalin 
as a result of the phosphorylation of GM at Ser46 and Ser65 
by cAMP-dependent protein kinase (PKA). This leads to the 
release of PP1 from the glycogen particles thereby preventing 
it from dephosphorylating the enzymes of glycogen metabo-
lism that remain associated with glycogen [1]. In contrast 
PPP1R6 lacks Ser65 and does not contain any other consen-
sus sequence for phosphorylation by PKA. However, it is 
intriguing that the N-terminal region of PPP1R6 contains 
three consensus sequences -PX(S/T)P- for phosphorylation 
by mitogen-activated protein kinases (MAPKs). It also con-
tains the sequence -LXRXXSL-, which is a consensus for 
phosphorylation by MAPK-activated protein kinase-2 (MAP-
KAP-K2) or calmodulin-dependent protein kinase-2 [15]. 
The P P 1 - G L complex is regulated by the active form of 
phosphorylase (phosphorylase a). Phosphorylase a binds to 
P P 1 - G L at nanomolar concentrations, preventing GL from 
dephosphorylating and activating glycogen synthase. This is 
an important mechanism for inhibiting glycogen synthesis as 
glycogenolysis is activated and vice versa [16]. However, like 
PPP1R5 [10], PPP1R6 lacks a high affinity binding site for 
phosphorylase a ([7], M.J. Doherty and P.T.W. Cohen, un-
published data). 
Further studies will be necessary to determine whether the 
complex of PPP1R6 with PP1 is subject to regulation by ex-
tracellular signals, such as insulin which stimulates the de-
phosphorylation of glycogen synthase in skeletal muscle. Since 
decreased insulin activation of glycogen synthase may contrib-
ute to insulin resistance in non-insulin-dependent diabetes 
mellitus [17,18], understanding the nature and regulation of 
the glycogen-associated forms of PP1 is of fundamental im-
portance. The multiplicity of glycogen-targetting subunits re-
vealed in this and other recent studies also implies that the 
relative contributions of all four glycogen-targetting subunits 
to the regulation of glycogen metabolism in skeletal muscle, 
liver and other tissues will need to be re-evaluated. 
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